Equities researchers at StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Down 1.7 %
Shares of NASDAQ AEZS opened at $4.03 on Friday. Aeterna Zentaris has a twelve month low of $3.96 and a twelve month high of $12.00. The company has a market cap of $7.23 million, a PE ratio of -0.27 and a beta of 1.55. The business’s 50 day moving average price is $5.39 and its two-hundred day moving average price is $6.84.
Aeterna Zentaris Company Profile
Featured Articles
- Five stocks we like better than Aeterna Zentaris
- Stock Sentiment Analysis: How it Works
- 3 Leveraged ETFs to Multiply Returns
- 3 Monster Growth Stocks to Buy Now
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Technology Stocks Explained: Here’s What to Know About Tech
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.